Investor Presentaiton
LOVVOLUS
JEUVEAUⓇ IS HIGHLY
EFFECTIVE FOR MILLENNIALS
>1-POINT (%) IMPROVEMENT ON THE GLS AT MAXIMUM FROWN
BY INVESTIGATOR ASSESSMENT BY VISIT
1.
2.
POOLED PHASE III POST HOC ANALYSIS¹
Study Findings²
•
•
•
JeuveauⓇwell-tolerated in both millennial
and non-millennial patients, and highly
effective for millennials
100% of millennials achieved greater than
1-pt improvement on Glabellar Line Scale
on days 7, 14, and 30
100% of millennials were satisfied or very
satisfied with treatment at day 7 and 30
EVB-001, EVB-002, and EVB-003 Phase III data
Ogilvie P, Jones DH, Avelar RL, Jonker A, Monroe R, Carruthers J. PrabotulinumtoxinA for Treatment of Millennials
With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data. Dermatologic
Surgery, June 2022.
p=0.089
62.5
51.1
p=0.038
p=0.064
p=0.063
p=0.005
100
100
100
94.8
95.0
90.2
90.8
MILLENNIALS
NON-MILLENNIALS
p=0.230
76.0
67.2
59.0
p=0.689
40.0
37.5
2 DAYS
7 DAYS
14 DAYS
30 DAYS
90 DAYS
120 DAYS 150 DAYS
DAYS POST-TREATMENT
n=733
n=/View entire presentation